Despite the fact that only 5–10% of the full-length SMN is produced by the SMN2 gene, the clinical severity of SMA is related to the number of SMN2 copies: patients with a higher copy number generally show a milder phenotype [13,14]. The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.